<html dir="ltr">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=Windows-1252">
<style>@font-face {
font-family: Wingdings;
}
@font-face {
font-family: Wingdings;
}
@font-face {
font-family: Calibri;
}
@font-face {
font-family: Tahoma;
}
@page WordSection1 {margin: 1.0in 1.0in 1.0in 1.0in; }
P.MsoNormal {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt
}
LI.MsoNormal {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt
}
DIV.MsoNormal {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt
}
H3 {
MARGIN: 12pt 0in; FONT-FAMILY: "Arial","sans-serif"; COLOR: black; FONT-SIZE: 12pt
}
A:link {
COLOR: blue; TEXT-DECORATION: underline
}
SPAN.MsoHyperlink {
COLOR: blue; TEXT-DECORATION: underline
}
A:visited {
COLOR: purple; TEXT-DECORATION: underline
}
SPAN.MsoHyperlinkFollowed {
COLOR: purple; TEXT-DECORATION: underline
}
P.MsoAcetate {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Tahoma","sans-serif"; FONT-SIZE: 8pt
}
LI.MsoAcetate {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Tahoma","sans-serif"; FONT-SIZE: 8pt
}
DIV.MsoAcetate {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Tahoma","sans-serif"; FONT-SIZE: 8pt
}
P.MsoListParagraph {
MARGIN: 0in 0in 0pt 0.5in; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt
}
LI.MsoListParagraph {
MARGIN: 0in 0in 0pt 0.5in; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt
}
DIV.MsoListParagraph {
MARGIN: 0in 0in 0pt 0.5in; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt
}
SPAN.Heading3Char {
FONT-FAMILY: "Arial","sans-serif"; COLOR: black; FONT-WEIGHT: bold
}
SPAN.EmailStyle19 {
FONT-FAMILY: "Calibri","sans-serif"; COLOR: windowtext
}
SPAN.BalloonTextChar {
FONT-FAMILY: "Tahoma","sans-serif"
}
SPAN.EmailStyle22 {
FONT-STYLE: normal; FONT-FAMILY: "Arial","sans-serif"; COLOR: teal; FONT-WEIGHT: normal; TEXT-DECORATION: none
}
.MsoChpDefault {
FONT-SIZE: 10pt
}
OL {
MARGIN-BOTTOM: 0in
}
UL {
MARGIN-BOTTOM: 0in
}
</style><style id="owaParaStyle">P {
MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px
}
P {
MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px
}
</style>
</head>
<body lang="EN-US" link="blue" vlink="purple" fPStyle="1" ocsi="0">
<div style="direction: ltr;font-family: Tahoma;color: #000000;font-size: 10pt;">
<p>Hi All,</p>
<p> </p>
<p>I received this from our Texas Dept of Health. Haven't had time to review it all yet, but thought I'd send it on.</p>
<p> </p>
<p>Jeanie Jaramillo</p>
<div style="FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 16px">
<hr tabindex="-1">
<div style="DIRECTION: ltr" id="divRpF480230"><br>
</div>
<div>
<div style="FONT-FAMILY: Times New Roman; DIRECTION: ltr; COLOR: #000000; FONT-SIZE: 12pt">
<div style="FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 16px">
<div></div>
<div>
<div class="WordSection1">
<p class="MsoNormal"><span>See below for information on today’s release of this nation report and here:
<a href="http://cp.mcafee.com/d/2DRPoA93gwd6QmnAkhPbPz9KVJd5x5NMQsCzBZUSCyMyUeLsQsICQQm4n73hOqenPhOrhLtNUQsIf3zhOr4vS4LUhSeGOffG2FPr9QJTEdCVPr9QJTEdCSndKO-C_R-ojpvp7tuVtdddzD7bKccsJt6OaaJTDel3PWApmU6CQjqb9K_9TLuZXTLsTsS029_FYOprlvzaSMFM078-JmcWox5IzF1KDFThpOfD_JfU8AGjSvOge1836RtCjBJetH6fQDYgkxgDjGjSvZcfVKxJ4QszDT3oK0GhEwd409yTipEwtH4Qg22LNBrjn4qw3kPgQg1vZfCjd40bY_ZFZ3h02_mH6pEwH0Qg1qfQJ6iQVlwq80Wbp4Qg211KDCy0Knd40r2NXq7Qd40Nfp-n85yUNfp-q80S3JoGXelo6XCVSA54-x" target="_blank">
http://www.healthyamericans.org/reports/drugabuse2013/release.php?stateid=TX</a> for the measures specific to Texas.<b></b></span></p>
<p class="MsoNormal"> </p>
<p class="MsoNormal">The Trust for America’s Health (TFAH) today released a report titled
<b><i>“Prescription Drug Abuse: Strategies to Stop the Epidemic 2013”</i></b> that includes (1) an overview of the problem, (2) an evaluation of State efforts designed to address the issue using a set of 10 indicators and (3) a review of national policy issues
and recommendations. The report can be found by visiting <a href="http://cp.mcafee.com/d/k-Kr4zqbbOa8VBVNATsSCyMyUUqejhO-Yrjhohs7nKqemjqqb2bzxEVd7bVEVdETKUYqem7xNEVdyfX2nY8X7lp7DR1kVJAWmXQ6PsVJAWmXQ6PrbCTpvjvW_c9ILIzKLsKCCCNPzBT66emKzp55mXPDaxVZicHs3jqpJ5ATvAXTLuZXTKrKr014_Q-pcJGLNBrokU03AvmH6tcgyShQwTjQXEIUrlSpemQVSIo_ivN1i52teFfp_QM_CW6QjhOevsdyU2F6y0Qg0Cbt9Cy1SIjh08a_6lJdshG0djd3h05_Q-pcQg0LP_SDQd40bZqIpCy2I3h05E_iQpbjBm1Ew3EJAjh0846Wuq82VsQg1Ib7JEvgQg34ZDVswmbz4ZDVEw3oeRyHIVlwrKrvBzy" target="_blank">
http://www.healthyamericans.org/reports/drugabuse2013/</a></p>
<p class="MsoNormal"> </p>
<h3 style="BACKGROUND: #f8e8d1">Report</h3>
<p style="LINE-HEIGHT: 13.5pt; TEXT-INDENT: -0.25in; BACKGROUND: #f8e8d1; MARGIN-LEFT: 0in" class="MsoNormal">
<span style="FONT-FAMILY: Wingdings; COLOR: black; FONT-SIZE: 10pt"><span>§<span>
</span></span></span><span><a href="http://cp.mcafee.com/d/1jWVIq6hAi43qbbOa8VBVNATsSCyMyUUqejhO-Yrjhohs7nKqemjqqb2bzxEVd7bVEVdETKUYqem7xNEVdyfX2nY8X7lp7DR1kVJAWmXQ6PsVJAWmXQ6PrbCTpvjvW_c9ILIzKLsKCCCNPzBT66emKzp55mXPDaxVZicHs3jr9J5ATvAXTLuZXTKrKr01A_Q-pcJGLNBrokU03AfckzmGKhY_ZFZc9hY_ZFYA3APhOyrlSpemQVSIo_ivN1i52teFfp_QM_CW6QjhOevsdyU2F6y0Qg0Cbt9Cy1SIjh08a_6lJdshG0djd3h05_Q-pcQg0LP_SDQd40bZqIpCy2I3h05E_iQpbjBm1Ew3EJAjh0846Wuq82VsQg1Ib7JEvgQg34ZDVswmbz4ZDVEw3oeRyHIVlwrKrgAy85opJ" target="_blank">The
news release is available here</a></span></p>
<p style="LINE-HEIGHT: 13.5pt; TEXT-INDENT: -0.25in; BACKGROUND: #f8e8d1; MARGIN-LEFT: 0in" class="MsoNormal">
<span style="FONT-FAMILY: Wingdings; COLOR: black; FONT-SIZE: 10pt"><span>§<span>
</span></span></span><span><a href="http://cp.mcafee.com/d/1jWVIg4wUp3zqbbOa8VBVNATsSCyMyUUqejhO-Yrjhohs7nKqemjqqb2bzxEVd7bVEVdETKUYqem7xNEVdyfX2nY8X7lp7DR1kVJAWmXQ6PsVJAWmXQ6PrbCTpvjvW_c9ILIzKLsKCCCNPzBT66emKzp55mXPDaxVZicHs3jr1J5ATvAXTLuZXTKrKr01hc2bL00s1ou2_mH6pJnpAVrjDqNzZ9_458k9QWAZD_j3-rErhd78VZMSbwaAq83h02oJQCq87qNd40wHYpmQRN6E0RcQd40n_jVAPh02_f_qvgQg0LRGNCq8aMd40mzZbhAJelo6y0eyShd40wgrFVEwbBPh06MIuSxZ3h0cjSvBO1oKcjSvCy0dwXmaKPBm1KVKY6Gv8Za9zqd" target="_blank">To
access the Rx Drug Abuse app, visit here</a></span></p>
<p style="LINE-HEIGHT: 13.5pt; TEXT-INDENT: -0.25in; BACKGROUND: #f8e8d1; MARGIN-LEFT: 0in" class="MsoNormal">
<span style="FONT-FAMILY: Wingdings; COLOR: black; FONT-SIZE: 10pt"><span>§<span>
</span></span></span><span><a href="http://cp.mcafee.com/d/k-Kr3xESyOYyyepuspdTdFEI8Ke6zAQsLL6QQm4n1RXCzBASCyMyUUqejhO-qejqdXKf6zBxUsqejoz-MB_2eNRmhVZglerpeBKZ1ITerpeBKZ1ISOVJSnQT-LP2rbX8XHTbFFFIsUVtNxzBHEShhlKYVOEuvkzaT0QS-rhpdTVeZXTLuZXCXCM0pfZfCjbqHYpmS5e00VJaveCeOf-C3CrLThp5krBXzKlmpdGXcDbqsXmcvFfUwF2xeDkDI_WovPt3q9EV7fK6Ns1kzh0q80j5KAPh0Xm9Ew45vzaSCK8R06FCxEw2_WvcCq80nV_XjW6y05-JmcPh1m1Ew2QvFqcBFOH0Qg1QmO9Ew423tfd41sKq80S5zSQfEq81yuPYKgb5NyuPYQg1I7qNlSsGMdTdTjapd1Kx" target="_blank">Download
audio of the news conference call here</a></span></p>
<h3 style="BACKGROUND: #f8e8d1">PDMP</h3>
<p style="LINE-HEIGHT: 13.5pt; TEXT-INDENT: -0.25in; BACKGROUND: #f8e8d1; MARGIN-LEFT: 0in" class="MsoNormal">
<span style="FONT-FAMILY: Wingdings; COLOR: black; FONT-SIZE: 10pt"><span>§<span>
</span></span></span><span><a href="http://cp.mcafee.com/d/FZsS720A96QmnAkhPbPz9KVJd5x5NMQsCzBZUSCyMyUeLsQsICQQm4n73hOqenPhOrhLtNUQsIf3zhOr4vS4LUhSeGOffG2FPr9QJTEdCVPr9QJTEdCSndKO-C_R-ojpvp7tuVtdddzD7bKccsJt6OaaJTDel3PWApmU6CT3qb9K_9TLuZXTLsTsS03mr87OIj_jVAPZch-DX6Nfw0e8dNSsGMN5UKHm4Otc8NS4_YKJ6EzZFV7ZFjWkB0ynZRTXjAp-7QEnmzZbhAJelo5RqMBeIpg8BRER8NRmxJnpAVrjDqNzZ9_458k9QWAZD_j3-rErhd78VZMSbwaAq83h02oJQCq87qNd40wHYpmQRN6E0RcQd40n_jVAPh02_f_qvgQg0LRGNCq8aMd40mzZbhAJelo6y0eyShd40wgrFVEwbBPh06MIuSxZ3h0cjSvBO1oKcjSvCy0dwXmaKPBm1KVIvXj3RmrIg9l" target="_blank">Reassessing
the Effectiveness of Prescription Monitoring Programs</a></span></p>
<p style="LINE-HEIGHT: 13.5pt; TEXT-INDENT: -0.25in; BACKGROUND: #f8e8d1; MARGIN-LEFT: 0in" class="MsoNormal">
<span style="FONT-FAMILY: Wingdings; COLOR: black; FONT-SIZE: 10pt"><span>§<span>
</span></span></span><span><a href="http://cp.mcafee.com/d/1jWVIi43qbbOa8VBVNATsSCyMyUUqejhO-Yrjhohs7nKqemjqqb2bzxEVd7bVEVdETKUYqem7xNEVdyfX2nY8X7lp7DR1kVJAWmXQ6PsVJAWmXQ6PrbCTpvjvW_c9ILIzKLsKCCCNPzBT66emKzp55mXPDaxVZicHs3joUSyOrLOtXTLuZXTdTdw0wqoH4GXmaNc_w0ej9-awQNm9kl87R8UDt57bCzD4XUUzyQvFqcBFOH0llH2kWNB0yaHhGhzGJ1l2EHcDVolFecyLyKyF3jZxrNmk1mpfNkxIVD-aRt5pA_5qjQHVeFW7NErlSpemQVSIo_ivN1i52teFfp_QM_CW6QjhOevsdyU2F6y0Qg0Cbt9Cy1SIjh08a_6lJdshG0djd3h05_Q-pcQg0LP_SDQd40bZqIpCy2I3h05E_iQpbjBm1Ew3EJAjh0846Wuq82VsQg1Ib7JEvgQg34ZDVswmbz4ZDVEw3oeRyHIVlwrKrjaMX5-jR" target="_blank">Prescription
Monitoring Programs: Do They Strike a Balance in the Battle of the Stakeholders?</a></span></p>
<h3 style="BACKGROUND: #f8e8d1">Overdose Prevention</h3>
<p style="LINE-HEIGHT: 13.5pt; TEXT-INDENT: -0.25in; BACKGROUND: #f8e8d1; MARGIN-LEFT: 0in" class="MsoNormal">
<span style="FONT-FAMILY: Wingdings; COLOR: black; FONT-SIZE: 10pt"><span>§<span>
</span></span></span><span><a href="http://cp.mcafee.com/d/k-Kr40Up4x8SyOYyyepuspdTdFEI8Ke6zAQsLL6QQm4n1RXCzBASCyMyUUqejhO-qejqdXKf6zBxUsqejoz-MB_2eNRmhVZglerpeBKZ1ITerpeBKZ1ISOVJSnQT-LP2rbX8XHTbFFFIsUVtNxzBHEShhlKYVOEuvkzaT0QSYrhpdTVeZXTLuZXCXCM0qPp0-lyvWvcCvFyfQ_oS9Y01OGQGOgbRc_52JfbHhYPY9OH0LqcFOJFVuGORoPrxasLErlSpemQVSIo_ivN1i52teFfp_QM_CW6QjhOevsdyU2F6y0Qg0Cbt9Cy1SIjh08a_6lJdshG0djd3h05_Q-pcQg0LP_SDQd40bZqIpCy2I3h05E_iQpbjBm1Ew3EJAjh0846Wuq82VsQg1Ib7JEvgQg34ZDVswmbz4ZDVEw3oeRyHIVlwrKrDN28gITHPktA" target="_blank">Opioid
Overdose Prevention -- Critical Opportunities</a></span></p>
<p style="LINE-HEIGHT: 13.5pt; TEXT-INDENT: -0.25in; BACKGROUND: #f8e8d1; MARGIN-LEFT: 0in" class="MsoNormal">
<span style="FONT-FAMILY: Wingdings; COLOR: black; FONT-SIZE: 10pt"><span>§<span>
</span></span></span><span><a href="http://cp.mcafee.com/d/FZsSd6QmnAkhPbPz9KVJd5x5NMQsCzBZUSCyMyUeLsQsICQQm4n73hOqenPhOrhLtNUQsIf3zhOr4vS4LUhSeGOffG2FPr9QJTEdCVPr9QJTEdCSndKO-C_R-ojpvp7tuVtdddzD7bKccsJt6OaaJTDel3PWApmU6CPhOrhpdTVeZXTLuZXCXCM0gdclyltH5oCvM070qoH4GaN-BmUS-C02B3oyJfzbWo1BjfNgHjPqKP9OSDeRz7Wj-8agEjFR9Xf-C7YTgSyqehPXxIn0l8Qg6y04NrFcQgeRyq811nUOJFHydg1GpEq80L-DP9Cy05-v-Q-xEw1vHlzcQglwq80J7Wmz9qsGMd40t5Iyq810wTjPh0nbCy0dxoZJ3W6y0oDI_bA2NsoDI_d40r1SIltDaI3tPrY7ceWQY" target="_blank">Take-Home
Naloxone for Opioid Overdose: Exploring the Legal, Policy and Practice Landscapes</a></span></p>
<p style="LINE-HEIGHT: 13.5pt; TEXT-INDENT: -0.25in; BACKGROUND: #f8e8d1; MARGIN-LEFT: 0in" class="MsoNormal">
<span style="FONT-FAMILY: Wingdings; COLOR: black; FONT-SIZE: 10pt"><span>§<span>
</span></span></span><span><a href="http://cp.mcafee.com/d/FZsS96QmnAkhPbPz9KVJd5x5NMQsCzBZUSCyMyUeLsQsICQQm4n73hOqenPhOrhLtNUQsIf3zhOr4vS4LUhSeGOffG2FPr9QJTEdCVPr9QJTEdCSndKO-C_R-ojpvp7tuVtdddzD7bKccsJt6OaaJTDel3PWApmU6CQrCQmjt-jLuZXTLuVKVI05J3RvU03yLEiT4aC87RR3i1_UX8_Wova1mC2e7U8DG-noh5kiW6CpkbQrmmVp1QSHIOsJFPJoN-A_y2Aa4WtiuP_Fx_dQdECzAs-Ur5M5id41Ew1cmWjd43JoCy0gl-cHqqUzk0qCq6y0b_FYOpEw1vD_JfEq80nWRoPd45o6y0bh-BEOmDaI3h07hr8Cy0g8dQYQg5OVEw3omfrg-xEw69XfOV0In69XfPh06MtH5npOH0TsTQrwKPFHXBLY" target="_blank">"Changing
Law from Barrier to Facilitator of Opioid Overdose Prevention"</a></span></p>
<p style="LINE-HEIGHT: 13.5pt; TEXT-INDENT: -0.25in; BACKGROUND: #f8e8d1; MARGIN-LEFT: 0in" class="MsoNormal">
<span style="FONT-FAMILY: Wingdings; COLOR: black; FONT-SIZE: 10pt"><span>§<span>
</span></span></span><span><a href="http://cp.mcafee.com/d/2DRPoOrhpuhh7cLecCXCQQm4n73hOqenTzqqb2bwWZPhOOrjhohssd79EVvd79J6ZT7zhOMYed79Ih_oi_x7oWH8Y-EaDdIDiTuwSrDdIDiTuwSrpsSXbWr_nVxdBZAtRXBQQQSessKUMNORQr8EGTusVkffGhBrwqrhhdEICXYDuZXTLuZPtPo086CaNaKRyIjfU03wdclyl5o_iHsrvj3_8WuaXiAGjS5L5jV48X4JAE2bsiMGJ7PfMDaI1no82Jdt-polzUITZ9QM3aCvyxmDCRtCjBJetH6fQDYgkxgDjGjSvZcfVKxJ4QszDT3oK0GhEwd409yTipEwtH4Qg22LNBrjn4qw3kPgQg1vZfCjd40bY_ZFZ3h02_mH6pEwH0Qg1qfQJ6iQVlwq80Wbp4Qg211KDCy0Knd40r2NXq7Qd40Nfp-n85yUNfp-q80S3JoGXelo6XCPbbblBFLLPya" target="_blank">Reducing
Drug Overdose through Law</a></span></p>
<p style="LINE-HEIGHT: 13.5pt; TEXT-INDENT: -0.25in; BACKGROUND: #f8e8d1; MARGIN-LEFT: 0in" class="MsoNormal">
<span style="FONT-FAMILY: Wingdings; COLOR: black; FONT-SIZE: 10pt"><span>§<span>
</span></span></span><span><a href="http://cp.mcafee.com/d/FZsS720srhpuhh7cLecCXCQQm4n73hOqenTzqqb2bwWZPhOOrjhohssd79EVvd79J6ZT7zhOMYed79Ih_oi_x7oWH8Y-EaDdIDiTuwSrDdIDiTuwSrpsSXbWr_nVxdBZAtRXBQQQSessKUMNORQr8EGTusVkffGhBrwqrhjdEICXYDuZXTLuZPtPo086CaNaKRyIjfU03AOvyEdclyl5i1Zie9ThpOUXbLoyqehSmGvmeElEaKO8AVyHJoyIOsEE2GSNCm5oqvkfH3Nk_OcG7Xelo6RtCjBJetH6fQDYgkxgDjGjSvZcfVKxJ4QszDT3oK0GhEwd409yTipEwtH4Qg22LNBrjn4qw3kPgQg1vZfCjd40bY_ZFZ3h02_mH6pEwH0Qg1qfQJ6iQVlwq80Wbp4Qg211KDCy0Knd40r2NXq7Qd40Nfp-n85yUNfp-q80S3JoGXelo6XCUhSCD_xlerJO" target="_blank">Colorado's
Fight for Third Party Naloxone Legislation</a></span></p>
<p style="LINE-HEIGHT: 13.5pt; TEXT-INDENT: -0.25in; BACKGROUND: #f8e8d1; MARGIN-LEFT: 0in" class="MsoNormal">
<span style="FONT-FAMILY: Wingdings; COLOR: black; FONT-SIZE: 10pt"><span>§<span>
</span></span></span><span><a href="http://cp.mcafee.com/d/k-Kr3xASyOYyyepuspdTdFEI8Ke6zAQsLL6QQm4n1RXCzBASCyMyUUqejhO-qejqdXKf6zBxUsqejoz-MB_2eNRmhVZglerpeBKZ1ITerpeBKZ1ISOVJSnQT-LP2rbX8XHTbFFFIsUVtNxzBHEShhlKYVOEuvkzaT0QSyOrhpdTVeZXTLuZXCXCM0gdclyltH5oCvM071nqk-u2ME-IpxwdclylbMQ-Evm7YIwWrlSpemQVSIo_ivN1i52teFfp_QM_CW6QjhOevsdyU2F6y0Qg0Cbt9Cy1SIjh08a_6lJdshG0djd3h05_Q-pcQg0LP_SDQd40bZqIpCy2I3h05E_iQpbjBm1Ew3EJAjh0846Wuq82VsQg1Ib7JEvgQg34ZDVswmbz4ZDVEw3oeRyHIVlwrKrVysT" target="_blank">"Legal
Interventions to Reduce Overdose Mortality: Naloxone Access and Overdose Good Samaritan Laws"</a></span></p>
<p class="MsoNormal"> </p>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</body>
</html>